These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

483 related items for PubMed ID: 29037205

  • 1. Vildagliptin ameliorates pulmonary fibrosis in lipopolysaccharide-induced lung injury by inhibiting endothelial-to-mesenchymal transition.
    Suzuki T, Tada Y, Gladson S, Nishimura R, Shimomura I, Karasawa S, Tatsumi K, West J.
    Respir Res; 2017 Oct 16; 18(1):177. PubMed ID: 29037205
    [Abstract] [Full Text] [Related]

  • 2. Dipeptidyl peptidase IV (DPP-IV) inhibition prevents fibrosis in adipose tissue of obese mice.
    Marques AP, Cunha-Santos J, Leal H, Sousa-Ferreira L, Pereira de Almeida L, Cavadas C, Rosmaninho-Salgado J.
    Biochim Biophys Acta Gen Subj; 2018 Mar 16; 1862(3):403-413. PubMed ID: 29154902
    [Abstract] [Full Text] [Related]

  • 3. APELIN-13 AMELIORATES LPS-INDUCED ENDOTHELIAL-TO-MESENCHYMAL TRANSITION AND POST-ACUTE LUNG INJURY PULMONARY FIBROSIS BY SUPPRESSING TRANSFORMING GROWTH FACTOR-Β1 SIGNALING.
    Liu H, Shi Q, Tang L, Wang H, Wang D.
    Shock; 2023 Jan 01; 59(1):108-117. PubMed ID: 36377383
    [Abstract] [Full Text] [Related]

  • 4. Profiling Proteinic Changes Induced by Vildagliptin Treatment in a Mouse Lung Transplantation Model: The Role of Kininogen-1.
    Tang Z, Zhai W, Wang Z, Hu Z, Zhang M.
    Ann Transplant; 2017 Mar 07; 22():128-137. PubMed ID: 28265106
    [Abstract] [Full Text] [Related]

  • 5. Soluble DPP-4 up-regulates toll-like receptors and augments inflammatory reactions, which are ameliorated by vildagliptin or mannose-6-phosphate.
    Lee DS, Lee ES, Alam MM, Jang JH, Lee HS, Oh H, Kim YC, Manzoor Z, Koh YS, Kang DG, Lee DH.
    Metabolism; 2016 Feb 07; 65(2):89-101. PubMed ID: 26773932
    [Abstract] [Full Text] [Related]

  • 6. Pirfenidone ameliorates early pulmonary fibrosis in LPS-induced acute respiratory distress syndrome by inhibiting endothelial-to-mesenchymal transition via the Hedgehog signaling pathway.
    Zhang R, Tan Y, Yong C, Jiao Y, Tang X, Wang D.
    Int Immunopharmacol; 2022 Aug 07; 109():108805. PubMed ID: 35504205
    [Abstract] [Full Text] [Related]

  • 7. Vildagliptin restores renal myogenic function and attenuates renal sclerosis independently of effects on blood glucose or proteinuria in zucker diabetic fatty rat.
    Vavrinec P, Henning RH, Landheer SW, Wang Y, Deelman LE, Dokkum RP, Buikema H.
    Curr Vasc Pharmacol; 2014 Aug 07; 12(6):836-44. PubMed ID: 24066937
    [Abstract] [Full Text] [Related]

  • 8. Resveratrol ameliorates lipopolysaccharide-induced epithelial mesenchymal transition and pulmonary fibrosis through suppression of oxidative stress and transforming growth factor-β1 signaling.
    Zhang YQ, Liu YJ, Mao YF, Dong WW, Zhu XY, Jiang L.
    Clin Nutr; 2015 Aug 07; 34(4):752-60. PubMed ID: 25234611
    [Abstract] [Full Text] [Related]

  • 9. Dipeptidyl-peptidase IV inhibition improves pathophysiology of heart failure and increases survival rate in pressure-overloaded mice.
    Takahashi A, Asakura M, Ito S, Min KD, Shindo K, Yan Y, Liao Y, Yamazaki S, Sanada S, Asano Y, Ishibashi-Ueda H, Takashima S, Minamino T, Asanuma H, Mochizuki N, Kitakaze M.
    Am J Physiol Heart Circ Physiol; 2013 May 15; 304(10):H1361-9. PubMed ID: 23504176
    [Abstract] [Full Text] [Related]

  • 10. Endothelial-to-mesenchymal transition in lipopolysaccharide-induced acute lung injury drives a progenitor cell-like phenotype.
    Suzuki T, Tada Y, Nishimura R, Kawasaki T, Sekine A, Urushibara T, Kato F, Kinoshita T, Ikari J, West J, Tatsumi K.
    Am J Physiol Lung Cell Mol Physiol; 2016 Jun 01; 310(11):L1185-98. PubMed ID: 27106288
    [Abstract] [Full Text] [Related]

  • 11. Vildagliptin ameliorates oxidative stress and pancreatic beta cell destruction in type 1 diabetic rats.
    Ávila Dde L, Araújo GR, Silva M, Miranda PH, Diniz MF, Pedrosa ML, Silva ME, de Lima WG, Costa DC.
    Arch Med Res; 2013 Apr 01; 44(3):194-202. PubMed ID: 23523961
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Beneficial effects of vildagliptin combined with miglitol on glucose tolerance and islet morphology in diet-controlled db/db mice.
    Ishibashi K, Hara A, Fujitani Y, Uchida T, Komiya K, Tamaki M, Abe H, Ogihara T, Kanazawa A, Kawamori R, Watada H.
    Biochem Biophys Res Commun; 2013 Nov 01; 440(4):570-5. PubMed ID: 24103756
    [Abstract] [Full Text] [Related]

  • 14. Vildagliptin blocks vascular injury in thoracic aorta of diabetic rats by suppressing advanced glycation end product-receptor axis.
    Matsui T, Nishino Y, Takeuchi M, Yamagishi S.
    Pharmacol Res; 2011 May 01; 63(5):383-8. PubMed ID: 21320599
    [Abstract] [Full Text] [Related]

  • 15. Vildagliptin, a CD26/DPP4 inhibitor, ameliorates bleomycin-induced pulmonary fibrosis via regulating the extracellular matrix.
    Liu Y, Qi Y.
    Int Immunopharmacol; 2020 Oct 01; 87():106774. PubMed ID: 32731178
    [Abstract] [Full Text] [Related]

  • 16. Mechanisms of action of the dipeptidyl peptidase-4 inhibitor vildagliptin in humans.
    Ahrén B, Schweizer A, Dejager S, Villhauer EB, Dunning BE, Foley JE.
    Diabetes Obes Metab; 2011 Sep 01; 13(9):775-83. PubMed ID: 21507182
    [Abstract] [Full Text] [Related]

  • 17. Dipeptidyl peptidase-4 inhibitor ameliorates early renal injury through its anti-inflammatory action in a rat model of type 1 diabetes.
    Kodera R, Shikata K, Takatsuka T, Oda K, Miyamoto S, Kajitani N, Hirota D, Ono T, Usui HK, Makino H.
    Biochem Biophys Res Commun; 2014 Jan 17; 443(3):828-33. PubMed ID: 24342619
    [Abstract] [Full Text] [Related]

  • 18. Neuroprotective effect of vildagliptin against cerebral ischemia in rats.
    El-Marasy SA, Abdel-Rahman RF, Abd-Elsalam RM.
    Naunyn Schmiedebergs Arch Pharmacol; 2018 Oct 17; 391(10):1133-1145. PubMed ID: 30022232
    [Abstract] [Full Text] [Related]

  • 19. Linagliptin ameliorates pulmonary fibrosis in systemic sclerosis mouse model via inhibition of endothelial-to-mesenchymal transition.
    Pei B, Zhang N, Pang T, Sun G.
    Mol Cell Biochem; 2022 Apr 17; 477(4):995-1007. PubMed ID: 34988855
    [Abstract] [Full Text] [Related]

  • 20. Linagliptin-mediated DPP-4 inhibition ameliorates kidney fibrosis in streptozotocin-induced diabetic mice by inhibiting endothelial-to-mesenchymal transition in a therapeutic regimen.
    Kanasaki K, Shi S, Kanasaki M, He J, Nagai T, Nakamura Y, Ishigaki Y, Kitada M, Srivastava SP, Koya D.
    Diabetes; 2014 Jun 17; 63(6):2120-31. PubMed ID: 24574044
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.